Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS. (Tables)

v3.20.2
FAIR VALUE MEASUREMENTS. (Tables)
 6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of used and related fair value for the warrants

Original Issuance   Exercise
Price		     Volatility     Risk Free
Interest
Rate		     Term
(years)		     Warrants
Outstanding		     Fair
Value		  
12/22/19   $ 1.00       122.0 %     0.16 %     2.50       5,500,000     $ 1,618,100  

 

Significant assumptions used and related fair value for the warrants as of December 31, 2019 were as follows:

 

Original Issuance   Exercise
Price		     Volatility     Risk Free
Interest
Rate		     Term
(years)		     Warrants
Outstanding		     Fair
Value		  
12/22/19   $ 1.00       76.0 %     1.66 %     3.00       5,500,000     $ 977,000  
Schedule of recurring and nonrecurring fair value measurements

    Fair                    
    Value     Level 1     Level 2     Level 3  
                         
Liabilities:                        
                         
Warrants   $ (1,618 )   $ —     $ —     $ (1,618 )
    $ (1,618 )   $ —     $ —     $ (1,618 )

 

                            Benefit Plan  
    Fair                       Percentage  
    Value     Level 1     Level 2     Level 3     Allocation  
Assets:                              
Derivative financial instruments   $ 2,438     $ 2,438     $ —     $ —          
                                         
Long-lived assets held-for-sale     70,400       —       —       70,400          
Defined benefit plan assets(1)                                        
(pooled separate accounts):                                        
Large U.S. Equity(2)     4,654       —       4,654       —       30 %
Small/Mid U.S. Equity(3)     2,348       —       2,348       —       15 %
International Equity(4)     2,596       —       2,596       —       17 %
Fixed Income(5)     6,056       —       6,056       —       38 %
    $ 88,492     $ 2,438     $ 15,654     $ 70,400          
                                         
Liabilities:                                        
Derivative financial instruments   $ (1,860 )   $ (1,860 )   $ —     $ —          
                                         
Warrants     (977 )     —       —       (977 )        
    $ (2,837 )   $ (1,860 )   $ —     $ (977 )        

 

(1) Included in derivative instruments in the consolidated balance sheets.
(2) This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
(3) This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
(4) This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
(5) This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.